Treats nosocomial pneumonia due to methicillin-susceptible S taphylococcus aureus…. ANDA 76710, held by Dr Reddys Labs Inc. Levofloxacin.
As of Nov 16, 2026, ANDA 76710 (Levofloxacin), held by Dr Reddys Labs Inc, was first approved by FDA on Jun 20, 2011, with 14 approved supplements and 0 published complete response letters.
Levofloxacin tablet is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4 ).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 2011 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Rx |
| Sep 20, 2024 | Supplement 20Labeling · Standard review | Approved | None posted |
| Aug 10, 2022 | Supplement 17Labeling · Standard review | Approved | None posted |
| Apr 6, 2020 | Supplement 15Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 10Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 9Labeling · Standard review | Approved | None posted |
| Sep 19, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| Sep 19, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 19, 2012 | Supplement 4Labeling · Standard review | Approved | None posted |
| Aug 24, 2012 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jan 23, 2012 | Supplement 2Labeling | Approved | None posted |
| Oct 21, 2011 | Supplement 1Labeling | Approved | None posted |
| Jun 20, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters